@@calvinl9426 Quite the opposite. This is the innovation Big Pharma has been waiting decades for. Novartis and AstraZeneca have already invested billions into gene editing - they understand the ROI potential of these technologies. The FDA expects to approve between 10-20 new gene therapies every year for the next 5 years. That is huge. The issue isn't whether or not Big Pharma will pursue gene editing therapies (they undoubtedly will, and already are). The issue will be whether or not they make them affordable for Joe Public.
@@johnniejay work the maths. Expensive treatment one time treatment meaning narrowing down numbers of consumer and human rights issue I o deal with. On going drugs keeping cash flow.
@@calvinl9426 Every technology in human history has become cheap by many orders of magnitude as methods of production have improved, and demand has massively increased. Why will biotech be any different? Sequencing the genome has already decreased from $3billion at the start of the century to under $1000 today. Just think if this treatment eliminiates cancer - that wont be a multi-billion dollar therapy, it will be a multi-trillion dollar therapy.
How successful does genetic editing have to be before the sexual majority lays aside their demand that people with disabilities perform at normal level while remaining disabled?
Nice discussion by Dr. Eric about gene editing and specially on CRISPR ,for what i was looking for a long time. Thanks. Love from Pakistan.
Interesting progress and as long it's to the benefit of mankind, why not?
This technology will kill pharmaceutical industry and they will do anything they can to stop it.
@@calvinl9426 Quite the opposite. This is the innovation Big Pharma has been waiting decades for. Novartis and AstraZeneca have already invested billions into gene editing - they understand the ROI potential of these technologies. The FDA expects to approve between 10-20 new gene therapies every year for the next 5 years. That is huge.
The issue isn't whether or not Big Pharma will pursue gene editing therapies (they undoubtedly will, and already are). The issue will be whether or not they make them affordable for Joe Public.
@@johnniejay work the maths. Expensive treatment one time treatment meaning narrowing down numbers of consumer and human rights issue I o deal with. On going drugs keeping cash flow.
@@calvinl9426 Every technology in human history has become cheap by many orders of magnitude as methods of production have improved, and demand has massively increased. Why will biotech be any different? Sequencing the genome has already decreased from $3billion at the start of the century to under $1000 today.
Just think if this treatment eliminiates cancer - that wont be a multi-billion dollar therapy, it will be a multi-trillion dollar therapy.
@@johnniejay thats not the argument. The point here is the motive of big pharma. Having one time cure would put them out of business.
I need this for NF1
Posted at: facebook.com/groups/crisper/
CRISPR Articles, Papers, Video, Podcasts, Discussion - 4,878 Members
How are they knocking out these viruses in pigs?
How successful does genetic editing have to be before the sexual majority lays aside their demand that people with disabilities perform at normal level while remaining disabled?